ACXP - acurxpharma.com Trailing Twelve Months Revenue Growth

Brandmark of Acurx Pharmaceuticals Inc. (ACXP)

Acurx Pharmaceuticals (ACXP) is developing advanced gastrointestinal antibiotics that preserve beneficial microflora and is implementing software robots for clinical data analysis. However, a narrow focus on combating C. difficile and competition from generics create risks. The relative sales growth over a 12-month period compared to last year confirms these trends, and the value of 0.00 reflects the balance of the current revenue metric.

Sales Growth YoY (TTM): Acurx Pharmaceuticals Inc. (ACXP) for 02/11/2024 - 11/18/2026

Acurx Pharmaceuticals Inc. - analytical breakdowns and key metrics (ACXP)

- stock price and consensus target price:
Analysis of all company metrics:Acurx Pharmaceuticals Inc.
Mass-produced product of Acurx Pharmaceuticals, Inc.

To build a high-quality portfolio, I use this indicator as a tool to measure the rolling year revenue expansion rate on a daily basis. This model eliminates quarterly gaps, allowing for a comparison of current revenues with the same period last year, which is critical for Acurx Pharmaceuticals (ACXP), as its clinical trial costs are growing faster than operating revenue, reflecting a lack of scaling leverage in the annual dynamics of sales proceeds over four quarters.

Competitor analysis for Acurx Pharmaceuticals